American Society for Histocompatibility & Immunogenetics - ASHI
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to American Society for Histocompatibility & Immunogenetics - ASHI — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
American Society for Histocompatibility & Immunogenetics (ASHI) – 52nd Annual Meeting
Event snapshot (from provided official source)
- Event name: ASHI 52nd Annual Meeting
- Dates: (not stated in the provided official website content)
- Venue: (not stated in the provided official website content)
- City & country: (not stated in the provided official website content)
What this event is (industry context)
ASHI’s annual meeting is centered on histocompatibility and immunogenetics, fields that support transplantation outcomes and immunological compatibility testing—commonly involving HLA (human leukocyte antigen) typing, antibody assessment, and related laboratory and clinical workflows. For research teams, diagnostic and transplant laboratory leaders, and biotech/diagnostics manufacturers, this kind of conference functions as an expert professional exchange plus an education and technology showcase.
1) Who attends (BUYERS / ATTENDEES)
For attendee-list (buyer) research, the most valuable segments at an ASHI-type meeting are typically not only general registrants, but decision-makers who influence diagnostic adoption, lab operations, testing strategies, and procurement tied to transplant immunology. The strongest “buyer” profiles usually include:
- Transplant program leaders and clinical directors (program outcomes, compatibility testing governance)
- Histocompatibility laboratory directors / medical directors (standards, methods, validation, QA)
- Laboratory managers and operational leaders (throughput, staffing, instrument utilization)
- Immunogenetics scientists / technical specialists (method selection influence, validation input)
- Quality & compliance leaders (CLIA/CAP/ISO alignment, documentation, audit readiness)
- Business development / channel leaders at diagnostics, reagents, and lab services firms (partnering and product placement)
- R&D and scientific affairs teams for diagnostics and instrumentation vendors (clinical evidence, workflow fit)
- Academic and research leadership (collaborations, research tooling, grants-aligned solutions)
Buyer fit is usually strongest when the company sells into transplant diagnostics, immunogenetics testing, lab instrumentation, or workflow infrastructure (data management, automation, validation services).
2) Where the show is happening + attendee geographic origin
The provided official source content does not include the venue or city/country, so we cannot reliably state the location. For geographic origin, ASHI meetings typically draw from the United States given ASHI’s primary footprint, and may include international attendees from transplant and diagnostic ecosystems (Europe, Canada, and other regions) depending on the program and sponsors.
Action for accurate targeting: we should confirm the actual city/country from the event page (or a schedule/registration page within the official site) so we can tailor geographic targeting (local/regional vs. national/global buyer density).
3) Audience reach (Local / National / Global)
Because the official snippet provided does not state the event’s logistics, we can only give a reasoned expectation: ASHI’s annual meeting generally functions as a national hub for U.S. transplant immunology and diagnostic professionals, with global visibility through international participation from adjacent scientific and clinical networks. The practical reach for buyers is usually strongest for U.S.-based procurement and lab leadership teams, plus internationally located diagnostics and research organizations when they sponsor or present.
4) Sample buyer company names (BUYERS ONLY) + Websites
Below is a practical “buyer-start” sample list for research outreach around histocompatibility, immunogenetics, and transplant diagnostics. These are sample buyer companies suitable for outreach and segmentation testing. Final buyer selection should be refined to match the client product category.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit | |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | https://www.thermofisher.com | Director, Clinical Diagnostics Business Development / Scientific Affairs Director | Strong presence in clinical diagnostics and lab workflows that support immunogenetics and transplant testing environments. | |
| 2 | Roche Diagnostics | https://diagnostics.roche.com | Head of Diagnostics Marketing / Senior Manager, Business Development (Clinical Diagnostics) | Relevant to immunology and diagnostic platforms used across specialized lab testing ecosystems. | |
| 3 | Abbott | https://www.abbott.com | Product Manager / Associate Director, Diagnostics Sales (Immunology) | Diagnostics portfolio and sales leadership can align with transplant immunology and lab adoption cycles. | |
| 4 | Sysmex America | https://www.sysmex-america.com | Director, Laboratory Solutions / Senior Product Specialist (Clinical Laboratory) | Laboratory testing ecosystem fit for buyers involved in instrument strategy and lab operations. | |
| 5 | Bio-Rad Laboratories | https://www.bio-rad.com | Director, Clinical Diagnostics / Business Development Manager (Immunology/Transplant Testing) | Tools and technologies that can support specialized immunology workflows and adoption in clinical labs. | |
| 6 | Danaher (Life Sciences / Diagnostics portfolio) | https://www.danaher.com | Vice President, Commercial Strategy (Diagnostics) / Director, Strategic Accounts | Portfolio coverage often intersects with lab instrumentation, diagnostics, and workflow systems for clinical testing. | |
| 7 | Illumina | https://www.illumina.com | Director, Genomics Clinical Solutions / Partnerships Lead | Genomics capabilities can align with immunogenetics workflows where sequencing and analysis are relevant. | |
| 8 | GenDx | https://www.gendx.com | Director of Clinical Affairs / Business Development Director (Transplant/Immunogenetics) | Company focus aligns closely with immunogenetics and HLA-adjacent laboratory applications. | |
| 9 | Thermo Fisher Scientific (Second entry for platform teams) | https://www.thermofisher.com | Senior Director, Strategy & Alliances (Diagnostics/Laboratory Informatics) | Informatics and partnerships can directly support adoption and integration into transplant testing operations. | |
| 10 | CARIS Life Sciences (if immunogenetics-related services are relevant) | https://www.carislife sciences.com | Director, Scientific Partnerships / Clinical Operations Lead | Scientific partnerships and advanced diagnostics influence clinical decision pathways—useful if the client product supports specialty testing. | |
| 11 | Konica Minolta (Life Science / Lab Solutions) | https://www.konicaminolta.com | Director, Life Science Solutions / Regional Sales Manager (Clinical Laboratory) | Buyer roles can connect with lab technology acquisition and integration plans. | |
| 12 | Stratec Biomedical Systems | https://www.stratec.com | Director, Automation Sales / VP, Business Development (Diagnostics Automation) | Automation and specimen/workflow solutions are often critical in high-throughput immunology labs. | |
| 13 | CIRRUS Logic? (not applicable) (excluded if not relevant) | (blank) | (blank) | (blank) | (This row should be replaced during final targeting.) |
| 13 | Velsera / lab informatics & workflow partners (replace with exact fit) | (blank) | Director, Lab Informatics / Head of Clinical Workflow Solutions | (This row is a placeholder; we recommend confirming the client product category and swapping in the correct matching informatics/vendor.) | |
| 14 | CareDx | https://www.caredx.com | Vice President, Commercial / Director, Market Access | Relevant where transplant monitoring or immunology-adjacent diagnostics intersect with transplant care decision-making. | |
| 15 | CTI BioPharma? (if not relevant, replace) | https://www.ctibiopharma.com | Director, Clinical Development Partnerships / Scientific Affairs Director | (Use only if the client product supports clinical development, immunology trials, or transplant-related studies.) | |
| 16 | ADMA Biologics (if relevant) | https://www.admabiologics.com | Head of Partnerships / Director, Business Development (Immunology) | (Use selectively; best fit depends on client offering alignment with immunology products/services.) | |
| 17 | Exosome Diagnostics (if relevant) | https://www.exosomedx.com | Director, Business Development / Head of Clinical Partnerships | (Use selectively; relevant only if the client offers transplant or immunogenetics-adjacent capabilities.) | |
| 18 | Invivoscribe | https://www.invivoscribe.com | Director, Clinical Applications / Business Development Manager (Immunogenetics) | Strong fit for immunogenetics-related research/clinical tool ecosystems. | |
| 19 | Genetic Testing / HLA services provider (replace with verified buyer list) | (blank) | Lab Director, Immunogenetics / Director, Clinical Laboratory Services | (Placeholder—best buyer companies should be confirmed to match the client product positioning and market.) | |
| 20 | Transplant laboratory network / reference lab (replace with verified buyer list) | (blank) | Director of Histocompatibility Laboratory / VP Laboratory Operations | (Placeholder—buyer density is high among reference labs and large transplant lab networks; confirm final targeting during research.) |
Note: Some rows above include placeholders to avoid asserting uncertain fits. Once the client product is reviewed (see section 8), we can replace placeholders with fully verified, high-fit buyer accounts and strengthen title targeting for the exact buying triggers.
5) Job profiles, industries & event type
Event type: Professional medical/clinical conference focused on histocompatibility, immunogenetics, transplantation-related testing, education, and scientific exchange.
Job profiles to prioritize:
- Laboratory Director (Histocompatibility / Immunogenetics)
- Medical Director (Transplant Lab / Immunology Diagnostics)
- Director of Clinical Affairs (Diagnostics)
- Scientific Affairs Director / Clinical Education Lead (Diagnostics)
- Quality Director / Regulatory Affairs (Lab quality systems)
- Laboratory Manager / Operations Manager (high-throughput testing)
- Procurement or Strategic Sourcing Lead (lab supplies & instruments)
- Business Development Director (Clinical Diagnostics)
- Regional Sales Director / Strategic Accounts Manager (laboratory customers)
- Informatics Leader (LIMS / lab workflow software) where applicable
Industries (from the provided industry list) to use for segmentation:
- Hospital & Health Care
- Medical Devices
- Medical Practice
- Pharmaceuticals (only if client solution supports clinical trials/clinical operations)
- Research
- Information Technology & Services (if the client offers lab informatics/LIMS/workflow platforms)
- Professional Training & Coaching (only if the client sells training/certification programs for lab adoption)
6) Estimated attendance (expected total footfall)
The provided official source content does not list attendance figures or exhibitor counts, so we cannot reliably estimate total footfall from the supplied text. For attendee-list research, we recommend collecting attendance expectations from the official schedule/meeting overview page or media kit.
7) Key focus areas & buyer engagement
Likely conference themes (industry-driven):
- Advances in HLA typing and immunogenetics methods
- Antibody-related testing and transplant compatibility interpretation
- Clinical lab validation, standardization, and quality systems
- Operational workflow improvements for specialized transplant labs
- Automation, informatics, and data handling (where relevant)
- Evidence sharing from clinical and laboratory research
- Educational sessions that influence method selection and training
Best engagement angles for buyers:
- “Workflow fit”: positioning around throughput, turnaround time, and standardization
- “Quality & validation support”: reducing adoption risk through documentation, performance data, and training
- “Clinical outcomes relevance”: framing around transplant decision support and reliability
- “Integration”: highlighting how the client product plugs into existing lab systems and processes
- “Compliance readiness”: addressing QA/QC, audit trails, and standard operating procedures
8) Client-product fit review (required next step)
We can refine and rank the best buyer segments precisely only after we review the client product positioning and target use case. Please share:
- Client website URL
- What the product does (1–2 sentences)
- Who uses it (lab director, procurement, R&D, clinical teams, etc.)
- Primary geography (if any)
Once we have the client website, we will:
- Identify the buyer decision-makers most likely to match the product’s adoption drivers
- Replace placeholders in the sample table with confirmed high-fit buyer accounts
- Rank titles by likely buying influence (director/manager/procurement/clinical affairs depending on the product)
- Recommend the best industry filters from the provided industry list for your exact offering
Important: We will align the buyer recommendations directly to what the client product solves (and avoid guessing matches that don’t fit).
9) Final recommendation (buying-readiness score for research)
This event is a strong fit for research into buyers in the transplant diagnostics, immunogenetics, and specialized lab operations ecosystem. Because the official snippet provided does not include the event’s dates and venue, we should validate those details before final outreach planning. After we receive the client website, we can produce a tighter top-tier buyer list and a cleaner, fully verified table of 15–20 buyer companies with role targeting.
Next step we need from you: Please share your client website URL so we can determine the best buyer profiles that match your product requirements.
Data sheet
American Society for Histocompatibility & Immunogenetics (ASHI) – Event Attendee & Buyer Profile Analysis
Event date: 26 October 2026 – 30 October 2026
Location: Montreal, Quebec, Canada
Event status: Upcoming
Research date: 30 June 2026
Event Overview
| Event Name | American Society for Histocompatibility & Immunogenetics (ASHI) 52nd Annual Meeting |
| Event Date | 26 October 2026 – 30 October 2026 |
| Event Status | Upcoming |
| Venue | Not publicly confirmed in the reviewed official source |
| City | Montreal |
| State / Region | Quebec (QC) |
| Country | Canada |
| Organizer | American Society for Histocompatibility & Immunogenetics (confirmed by event branding/title) |
| Official Event Website | ashi52ndannualmeeting.eventscribe.net |
| Event Type | Annual scientific meeting / professional association conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Education & Training |
| Audience Reach | Likely North American with international specialist participation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for volume metrics; confirmed for event existence and branding only from reviewed official source |
| Main Purpose of Event | Professional education, scientific exchange, laboratory practice alignment, industry engagement, and networking in histocompatibility and immunogenetics |
About the Event
The ASHI 52nd Annual Meeting is the flagship annual meeting associated with the American Society for Histocompatibility & Immunogenetics. Based on the reviewed official event page, the 2026 edition is confirmed as the ASHI 52nd Annual Meeting and is scheduled for 26–30 October 2026 in Montreal, Quebec, Canada. The available official source confirms the event identity but does not publicly disclose venue, attendance figures, exhibitor counts, or a named attendee directory in the reviewed content.
From a commercial and lead-generation perspective, this event is highly relevant for organizations serving transplant diagnostics, immunogenetics laboratories, hospital systems, clinical lab operations, research institutions, quality/compliance functions, and specialized medical suppliers. Buyer engagement is likely concentrated among laboratory leadership, medical directors, procurement stakeholders, scientific decision-makers, and diagnostic technology users rather than mass-market trade buyers. This makes the meeting more valuable for targeted account-based outreach than for high-volume attendee-list assumptions.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Histocompatibility laboratory directors | Transplant labs, hospital-based immunology labs, academic medical centers | High influence on platform selection, assay adoption, workflow standards, and validation priorities | Core buyers for HLA typing, antibody detection, software, lab automation, and QC tools |
| Medical directors and transplant physicians | Hospitals, transplant programs, clinical departments | Clinical influence over test utilization, protocol alignment, and medical acceptance | Important for clinical evidence, adoption credibility, and enterprise approvals |
| Laboratory operations and quality managers | Clinical laboratories, reference labs, university hospitals | Influence purchasing through workflow, accreditation, staffing, and quality requirements | Relevant for consumables, middleware, documentation, training, and automation systems |
| Procurement and sourcing teams | Hospital systems, academic health networks, centralized purchasing groups | Commercial gatekeepers for contracts, vendor onboarding, and purchasing compliance | Critical for closing deals and converting technical interest into contracted spend |
| Research scientists and principal investigators | Universities, research institutes, translational medicine programs | Influence innovation purchasing, pilot studies, and publication-led adoption | Useful for early-stage product validation and scientific collaborations |
| Diagnostic and assay program managers | Clinical diagnostics companies, lab medicine groups | Evaluate product performance, interoperability, and implementation fit | High-value contacts for platform upgrades and long-cycle buying discussions |
| Industry sponsors and partner organizations | Medical device firms, diagnostics suppliers, laboratory software vendors | Can be partners, channel collaborators, or competitive intelligence sources | Relevant for alliances, distribution, co-marketing, and solution bundling |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Montreal | Confirmed host city | Local hospitals, laboratories, universities, and clinical research stakeholders | Useful for regional meetings and nearby institution outreach |
| Quebec | Likely provincial participation | University health centers, transplant labs, public hospital systems | French-speaking market relevance may affect outreach and materials |
| Eastern Canada | Likely attendees from Ontario and neighboring provinces | Strong concentration of academic medicine and reference labs | Accessible travel corridor for Canadian specialists |
| United States | Likely major source market due to ASHI association identity | Hospital systems, transplant centers, diagnostics firms, academic labs | Expected core buyer geography for B2B follow-up |
| International specialist markets | Possible but not confirmed | Niche scientific and clinical participants | Treat as likely international specialist reach rather than mass global attendance |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | The event is tied to a named professional society annual meeting and is likely to draw attendees from across the United States and Canada rather than serving only a local market. |
| International | Secondary reach likely | Because the 2026 edition is in Montreal, cross-border and specialist international participation is plausible, but no public current-year attendance geography was confirmed in the reviewed source. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| No publicly posted current-year buyer, attendee, exhibitor, or speaker organization list identified in the reviewed official source | N/A | The official event page reviewed confirms the meeting name but does not disclose buyer-side organization names in the supplied source content. | N/A | Laboratory Director; Medical Director; Procurement Manager; Transplant Program Director | Confirmed official event existence only |
This event is suitable for B2B attendee list building only after obtaining additional official directories, agenda pages, sponsor listings, exhibitor pages, abstract affiliations, or speaker organizations. Based on the reviewed source alone, named buyer-company extraction is not yet supportable.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Laboratory Director | Laboratory Operations | Director | Core technical and budget influence for histocompatibility testing platforms and laboratory workflows |
| 2 | Medical Director | Clinical Leadership | Director / Executive | Approves clinical alignment, diagnostic protocols, and evidence-based adoption |
| 3 | Transplant Program Director | Clinical Programs | Director | Connects lab purchasing to care delivery, patient outcomes, and transplant coordination needs |
| 4 | Procurement Manager | Procurement | Manager | Handles vendor qualification, purchasing process, and contract execution |
| 5 | Strategic Sourcing Manager | Supply Chain / Sourcing | Manager | Relevant for reagent, instrument, and service contract consolidation |
| 6 | Quality Manager | Quality / Compliance | Manager | Important where solutions affect accreditation, documentation, and reproducibility |
| 7 | Principal Investigator / Research Scientist | Research | Senior Individual Contributor / Director | Drives evaluations, pilot projects, and scientific adoption pathways |
| 8 | Director of Clinical Laboratory Services | Laboratory Administration | Director | Owns operational scale, staffing, and platform standardization decisions |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core end-user environment for transplant and laboratory services | Clinical buyers, lab leaders, hospital procurement |
| 2 | Medical Devices | Relevant for diagnostic equipment and specialized laboratory systems | Instrumentation, analyzers, workflow hardware |
| 3 | Biotechnology | Strong fit for molecular testing, immunogenetics, and assay innovation | R&D collaborations and advanced testing solutions |
| 4 | Pharmaceuticals | Relevant for transplant medicine and associated clinical support ecosystems | Partnerships, disease-area support, and scientific engagement |
| 5 | Research | Academic and translational research institutions are likely participant groups | Scientific pilots, validation projects, and research procurement |
| 6 | Higher Education | University-affiliated medical centers and labs are relevant decision environments | Academic labs and teaching hospital networks |
| 7 | Information Technology & Services | Relevant where lab software, interoperability, data management, and reporting are involved | LIS integration, analytics, workflow software |
| 8 | Government Administration | Potential fit for public health systems, public hospitals, and procurement entities | Public-sector health procurement and policy-linked programs |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | Reviewed official event page | No volume metric was visible in the supplied official content |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Reviewed official event page | Sponsor tier labels were visible, but sponsor counts and names were not disclosed in the supplied content |
| Buyer count | Not publicly confirmed | Unconfirmed | Reviewed official event page | No attendee segmentation numbers available in the reviewed source |
| Speaker count | Not publicly confirmed | Unconfirmed | Reviewed official event page | Schedule link exists, but no speaker totals were available in the supplied source text |
| Sponsor count | At least multiple sponsor tiers indicated | Partially confirmed | Reviewed official event page | Diamond, Platinum, Silver, Bronze, and Friends of ASHI tiers were visible; named sponsors were not shown in the supplied text |
| Historical attendance | Not established from reviewed materials | Unavailable | No verified prior-year metric supplied | No historical attendance claim made to avoid unsupported estimates |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Histocompatibility testing | Reliable and clinically validated testing workflows | Demonstrations, technical consultations, validation support | Assays, typing platforms, reagents, instrumentation |
| Immunogenetics research | Data quality, study support, translational tools | Scientific partnerships and pilot projects | Research kits, analytics software, data platforms |
| Laboratory operations | Efficiency, throughput, staff productivity, standardization | ROI-led conversations with lab and operations leaders | Automation, middleware, workflow redesign, service contracts |
| Quality and compliance | Documentation, audit readiness, reproducibility | Compliance-centric messaging with quality managers | QC products, validation services, documentation tools |
| Procurement and contracting | Vendor qualification, pricing, contract structure | Structured follow-up with sourcing and purchasing teams | Contract pricing, multi-site supply programs, implementation support |
| Clinical data and software | Data management, reporting, interoperability | Engagement with lab IT, operations, and informatics stakeholders | LIS integration, reporting software, decision-support tools |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | The meeting likely concentrates specialized clinical and laboratory decision-makers with strong solution relevance. |
| Decision-maker availability | High | Association annual meetings typically attract directors, medical leaders, and senior scientific stakeholders. |
| Data collection potential | Medium | Potential is strong if agenda, sponsor, speaker, and exhibitor pages become available; currently limited from the reviewed source. |
| Apollo targeting potential | High | The audience can be approximated well through hospital, biotech, diagnostics, research, and lab leadership filters. |
| Geographic targeting potential | High | North America-focused targeting is practical, especially U.S. and Canadian transplant and academic medical hubs. |
| Best outreach approach | Account-based, technical-value outreach | Use scientific credibility, workflow improvement, compliance support, and clinical outcome messaging. |
| Overall lead quality | High | High-value niche audience, but success depends on precise targeting rather than mass outreach. |
| Best use case | Specialized B2B prospecting and conference-based account mapping | Best for laboratory, diagnostics, software, and clinical service vendors with focused ICPs. |
| Limitations / risks | Medium | Named participant data was not publicly visible in the reviewed source, so attendee-list assumptions should be avoided until more official pages are reviewed. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Biotechnology; Pharmaceuticals; Research; Higher Education; Information Technology & Services; Government Administration | Capture likely end users, institutional buyers, and technical decision-makers |
| Departments | Operations; Procurement; Research; Information Technology; Clinical; Quality Assurance | Align outreach with operational, technical, and purchasing roles |
| Seniority | Director; VP; Head; CXO; Manager | Prioritize budget holders and implementation influencers |
| Job titles | Laboratory Director; Medical Director; Director of Clinical Laboratory Services; Procurement Manager; Strategic Sourcing Manager; Transplant Program Director; Quality Manager; Research Scientist; Principal Investigator | Directly maps to likely ASHI attendee roles |
| Geography | United States; Canada; prioritize Quebec, Ontario, Northeast U.S., Midwest U.S., major academic medical hubs | Focus on probable attendee origin and transplant/lab density |
| Employee size | 201–500; 501–1,000; 1,001–5,000; 5,001–10,000; 10,001+ | Target institutions large enough to operate advanced transplant and specialized laboratory programs |
| Keywords | histocompatibility, immunogenetics, HLA, transplant laboratory, transplant immunology, tissue typing, donor matching, antibody testing, clinical laboratory, transplant program | Improve precision in niche market discovery |
| Technologies, if relevant | LIS, laboratory informatics, molecular diagnostics software, workflow automation tools | Useful for software and interoperability vendors |
| Revenue range, if relevant | Mid-market to enterprise health systems and established diagnostics organizations | Supports contractable accounts with budget capacity |
| Company type | Hospitals, academic medical centers, research institutions, public health systems, diagnostic labs | Most likely organizational types represented or relevant to the meeting |
Suggested Apollo Search Logic: ("histocompatibility" OR immunogenetics OR HLA OR "transplant laboratory" OR "tissue typing" OR "donor matching") AND (Director OR Manager OR "Medical Director" OR "Laboratory Director" OR "Procurement Manager" OR "Transplant Program Director") AND (hospital OR laboratory OR transplant OR immunology).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| ASHI 52nd Annual Meeting official event page | Official event website | Confirmed event branding as “ASHI 52nd Annual Meeting”; confirmed sponsor-tier presence; confirmed existence of schedule navigation; provided official 2026 event context | High for event identity; limited for venue, attendance, and named participant data because these were not present in the reviewed source text |
| User-supplied event details | Provided event metadata | City: Montreal; State/Region: QC; Country: Canada; Start date: 2026-10-26; End date: 2026-10-30 | Used as provided because the supplied official page text did not contradict these details |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to American Society for Histocompatibility & Immunogenetics - ASHI — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds